UC UC UC UC UC UC UC UC UC UC UC .../ DE000HR5M072 /
14.06.2024 9:01:19 | Изменение+0.040 | Бид9:10:16 | Предложение9:10:16 | Базовый актив | Цена исполнения | Дата истечения | Тип опциона |
---|---|---|---|---|---|---|---|
16.580EUR | +0.24% | 16.700 Величина цены спроса: 8,000 |
16.740 Величина цены предложения: 8,000 |
SWISSCOM N | 334.6069 CHF | 31.12.2078 | Call |
GlobeNewswire
9:01
Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients ...
GlobeNewswire
9:00
Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investi...
GlobeNewswire
9:00
Editas Medicine Announces New Safety and Efficacy Data from the EdiTHAL Trial of Reni-cel in 7 Patie...
GlobeNewswire
9:00
Samsung Bioepis Presents Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimila...
GlobeNewswire
8:00
Cabaletta Bio Reports Positive Initial Clinical Data from Phase 1/2 RESET-Myositis™ and RESET-SLE™ T...
GlobeNewswire
7:00
Molecular Partners Presents Positive Preclinical Data for First Switch-DARPin Candidate MP0621 at EH...
- Первая страница
- Назад
- 1
- 2
- 3
- 4
- Следующий
- Последняя страница